Bibliographic record
Abstract
Obesity management is complex; medications must be used in conjunction with behavioural changes and monitoring by health professionals.Injectable drugs for weight management include glucagon-like peptide-1 (GLP-1) receptor agonists (e.g.liraglutide, semaglutide) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (e.g.tirzepatide).These drugs contribute to weight loss by mimicking the incretin hormones GLP-1 and GIP to reduce appetite, change food enjoyment, slow stomach emptying and stimulate insulin release.Regaining weight is common when these drugs are stopped, so they usually need to be continued long term.Relatively minor gastrointestinal issues are common.There is also a small but real risk of more serious adverse effects, including gallstones and pancreatitis.It is important to monitor mental health, as these drugs can change a patient's relationship with food, and they may be misused by those without obesity.Injectable drugs for weight management individual. 1 Injectable weight-loss drugs should be used as an adjunct to behavioural interventions.In clinical trials for these drugs, all participants received advice about behavioural and lifestyle modifications.[2][3][4] By aiding appetite regulation and reducing cravings, these drugs help patients adhere to behavioural changes more effectively. 5ny individuals living with obesity experience micronutrient deficiencies, disordered eating behaviours, and sarcopenia, 6,7 all of which can be worsened by weight loss.Prescribers must conduct thorough initial assessment, monitor regularly, and be able to coordinate support for patients, ideally with a multidisciplinary team.An individualised, integrated approach ensures that obesity management prioritises long-term health and overall wellbeing.8 Mechanisms of actionInjectable drugs to manage weight work by mimicking the incretin hormones GLP-1 and GIP.They act either at the GLP-1 receptor alone (liraglutide, semaglutide) or at both GLP-1 and GIP receptors (tirzepatide).In the brain this affects appetite centres, specifically the hypothalamus and mesolimbic pathway.The effect is to increase satiety, as well as reduce or change enjoyment of food.In the gut, movement of food is slowed, resulting in a prolonged feeling of fullness.The drugs also act on the pancreas, stimulating insulin production and reducing glucagon, which is why they were first developed for use in diabetes.These combined effects result in weight loss.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.004 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.001 | 0.002 |
| Insufficient payload (model declined to judge) | 0.097 | 0.038 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".